logo
  • 首页
  • 学术期刊
  • 论文检测
  • AIGC检测
  • 热点
  • 更多
    • 数据

CemiplimabLack of efficacy: case report

被引:0
|
作者:
机构:
来源:
Reactions Weekly | 2023年 / 1981卷 / 1期
关键词:
D O I:
10.1007/s40278-023-48698-3
中图分类号:
学科分类号:
摘要:
引用
收藏
页码:119 / 119
相关论文
共 50 条
  • [21] DopamineLack of efficacy: case report
    Reactions Weekly, 2022, 1930 (1) : 238 - 238
  • [22] AntineoplasticsLack of efficacy: case report
    Reactions Weekly, 2022, 1932 (1) : 85 - 85
  • [23] AntineoplasticsLack of efficacy: case report
    Reactions Weekly, 2021, 1853 (1) : 52 - 52
  • [24] NorepinephrineLack of efficacy: case report
    Reactions Weekly, 2020, 1806 (1) : 213 - 213
  • [25] AntineoplasticsLack of efficacy: case report
    Reactions Weekly, 2022, 1907 (1) : 57 - 57
  • [26] OctreotideLack of efficacy: case report
    Reactions Weekly, 2022, 1903 (1) : 298 - 298
  • [27] TetrabenazineLack of efficacy: case report
    Reactions Weekly, 2022, 1910 (1) : 439 - 439
  • [28] SalbutamolLack of efficacy: case report
    Reactions Weekly, 2023, 1964 (1) : 374 - 374
  • [29] RituximabLack of efficacy: case report
    Reactions Weekly, 2022, 1910 (1) : 422 - 422
  • [30] CelecoxibLack of efficacy: case report
    Reactions Weekly, 2021, 1842 (1) : 114 - 114
← 12345 →